Tocilizumab for giant cell arteritis
Author:
Affiliation:
1. Hauenstein Neurosciences, Mercy Health Saint Mary's; Grand Rapids Michigan USA
2. Department of Ophthalmology; University of Colorado Anschutz Medical Campus; Denver Colorado USA
Publisher
Wiley
Subject
Pharmacology (medical)
Reference58 articles.
1. Birchwood C Tuckwell K Dimonaco S Klearman M Collinson N Stone JH Tocilizumab in patients with giant cell arteritis: analysis of new-onset and relapsing subgroups from a randomized, double-blind, placebo-controlled, phase 3 trial Investigative Ophthalmology & Visual Science 2017 58 8
2. Haskova Z Strand V Dimonaco S Tuckwell K Klearman M Collinson N Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomized controlled trial Investigative Ophthalmology & Visual Science 2018 59 9
3. Mollan SP Tuckwell K Dimonaco S Klearman M Collinson N Stone JH Tocilizumab in patients with giant cell arteritis: results from a Phase 3 randomized controlled trial Journal of Headache and Pain 2018 19 10.1186/s10194-018-0900-0
4. Glucocorticoid dosages and acute-phase reactant levels at giant cell arteritis flare in a randomized trial of tocilizumab;Stone;Arthritis & Rheumatology,2019
5. Trial of tocilizumab in giant-cell arteritis;Stone;New England Journal of Medicine,2017
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis;Frontiers in Pharmacology;2024-05-20
2. Broader Perspective on Atherosclerosis—Selected Risk Factors, Biomarkers, and Therapeutic Approach;International Journal of Molecular Sciences;2024-05-10
3. Neuro-ophthalmic challenges and multi-morbidity in vasculitis among the older adults;Expert Review of Clinical Immunology;2024-04-09
4. Giant Cell Arteritis: Advances in Understanding Pathogenesis and Implications for Clinical Practice;Cells;2024-01-31
5. How beneficial and safe is tocilizumab for patients with giant cell arteritis? A Cochrane Review summary with commentary;International Journal of Rheumatic Diseases;2022-07-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3